Questions about getting a COVID-19 vaccine? See the latest on our blog

Drug Changes


Here you will find a listing of the drugs that have been changed on our drug list (formulary) for the plan year you select.

To request Medicare Part D prescription drug coverage determinations (including tiering or formulary exception requests) please use the following form:


Votrient Tablet 200 MG Oral


Post Date:
1/29/2024
Effective Date:
2/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
PAZOPanib HCl Tablet 200 MG Oral Tier 5 PA, QL Molecular Target Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Vyvanse Capsule 10 MG Oral


Post Date:
1/29/2024
Effective Date:
2/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Lisdexamfetamine Dimesylate Capsule 10 MG Oral Tier 2 QL Attention Deficit Hyperactivity Disorder Agents, Amphetamines
* Please reference your Evidence of Coverage for applicable cost-sharing.

Vyvanse Capsule 20 MG Oral


Post Date:
1/29/2024
Effective Date:
2/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Lisdexamfetamine Dimesylate Capsule 20 MG Oral Tier 2 QL Attention Deficit Hyperactivity Disorder Agents, Amphetamines
* Please reference your Evidence of Coverage for applicable cost-sharing.

Vyvanse Capsule 30 MG Oral


Post Date:
1/29/2024
Effective Date:
2/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Lisdexamfetamine Dimesylate Capsule 30 MG Oral Tier 2 QL Attention Deficit Hyperactivity Disorder Agents, Amphetamines
* Please reference your Evidence of Coverage for applicable cost-sharing.

Vyvanse Capsule 40 MG Oral


Post Date:
1/29/2024
Effective Date:
2/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Lisdexamfetamine Dimesylate Capsule 40 MG Oral Tier 2 QL Attention Deficit Hyperactivity Disorder Agents, Amphetamines
* Please reference your Evidence of Coverage for applicable cost-sharing.

Vyvanse Capsule 50 MG Oral


Post Date:
1/29/2024
Effective Date:
2/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Lisdexamfetamine Dimesylate Capsule 50 MG Oral Tier 2 QL Attention Deficit Hyperactivity Disorder Agents, Amphetamines
* Please reference your Evidence of Coverage for applicable cost-sharing.

Vyvanse Capsule 60 MG Oral


Post Date:
1/29/2024
Effective Date:
2/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Lisdexamfetamine Dimesylate Capsule 60 MG Oral Tier 2 QL Attention Deficit Hyperactivity Disorder Agents, Amphetamines
* Please reference your Evidence of Coverage for applicable cost-sharing.

Vyvanse Capsule 70 MG Oral


Post Date:
1/29/2024
Effective Date:
2/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Lisdexamfetamine Dimesylate Capsule 70 MG Oral Tier 2 QL Attention Deficit Hyperactivity Disorder Agents, Amphetamines
* Please reference your Evidence of Coverage for applicable cost-sharing.

Zulresso Solution 100 MG/20ML Intravenous


Post Date:
1/29/2024
Effective Date:
2/1/2024
Type of Change:
Drug removed
Reason Changed:
Not a self-administered drug
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Citalopram Hydrobromide Tablet 10 MG Oral Tier 1 SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors)
Citalopram Hydrobromide Tablet 20 MG Oral Tier 1 SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors)
Citalopram Hydrobromide Tablet 40 MG Oral Tier 1 SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors)
FLUoxetine HCl Capsule 10 MG Oral Tier 1 SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors)
FLUoxetine HCl Capsule 20 MG Oral Tier 1 SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors)
FLUoxetine HCl Capsule 40 MG Oral Tier 1 SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors)
Sertraline HCl Tablet 100 MG Oral Tier 1 SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors)
Sertraline HCl Tablet 25 MG Oral Tier 1 SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors)
Sertraline HCl Tablet 50 MG Oral Tier 1 SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors)
* Please reference your Evidence of Coverage for applicable cost-sharing.

Alphagan P Solution 0.1 % Ophthalmic


Post Date:
2/22/2024
Effective Date:
3/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Brimonidine Tartrate Solution 0.1 % Ophthalmic Tier 2 Ophthalmic Intraocular Pressure Lowering Agents, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Ciprodex Suspension 0.3-0.1 % Otic


Post Date:
2/22/2024
Effective Date:
3/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Ciprofloxacin-Dexamethasone Suspension 0.3-0.1 % Otic Tier 2 Otic Agents
* Please reference your Evidence of Coverage for applicable cost-sharing.

Condylox Gel 0.5 % External


Post Date:
2/22/2024
Effective Date:
3/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Podofilox Gel 0.5 % External Tier 4 Dermatological Agents, Other
* Please reference your Evidence of Coverage for applicable cost-sharing.

Livalo Tablet 1 MG Oral


Post Date:
2/22/2024
Effective Date:
3/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Pitavastatin Calcium Tablet 1 MG Oral Tier 2 QL Dyslipidemics, HMG CoA Reductase Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Livalo Tablet 2 MG Oral


Post Date:
2/22/2024
Effective Date:
3/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Pitavastatin Calcium Tablet 2 MG Oral Tier 2 QL Dyslipidemics, HMG CoA Reductase Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.

Livalo Tablet 4 MG Oral


Post Date:
2/22/2024
Effective Date:
3/1/2024
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available
Applies To:
All Rx Plans

Alternative Drugs


Drug Tier* Drug Restrictions Therapy Class
Pitavastatin Calcium Tablet 4 MG Oral Tier 2 QL Dyslipidemics, HMG CoA Reductase Inhibitors
* Please reference your Evidence of Coverage for applicable cost-sharing.